复方灵芝口服液对睡眠剥夺大鼠睡眠的影响

摘要：目的：探讨复方灵芝口服液对睡眠剥夺大鼠睡眠的影响。方法：利用腹腔注射氯苯丙氨酸（PCPA）制造睡眠剥夺模型,参照《保健食品检验与评价技术规范实施手册》（2003版）中的标准检测复方灵芝口服液是否具有改善睡眠的作用。结果：复方灵芝口服液可延长戊巴比妥钠诱导的睡眠时间（P＜0.05）,但对增加睡眠剥夺大鼠的入睡动物数和缩短巴比妥钠诱导的潜伏期无明显作用（P＞0.05）,且无直接睡眠作用。结论：复方灵芝口服液可明显延长戊巴比妥钠诱导的睡眠时间。     

睡眠剥夺对认知功能的影响研究进展

睡眠剥夺(sleep deprivation,SD)是一种由于环境或自身原因无法满足正常睡眠的情况.认知是个体认识和理解事物的心理过程,包括对自己与环境的确定、感知、注意、学习和记忆、思维和语言等.认知功能由多个认知域组成,包括记忆、计算、时空间定向、结构能力、执行能力、语言理解和表达及应用等方面.SD可对认知功能产生一定影响,如清醒度、警觉性及注意力下降;感官知觉能力下降;学习记忆能力下降等.SD可能增加氧自由基产生,改变神经递质动态分布,损伤海马结构,诱导异常基因表达以及抑制长时程增强效应,引起脑内神经结构状态紊乱,导致认知功能障碍.本文从SD所致认知障碍的表现形式,认知障碍的可能机制以及SD与神经变性的关系三个方面探讨SD对认知功能的影响.     

莫达非尼对睡眠剥夺条件下工作记忆的影响

目的:观察在睡眠剥夺条件下莫达非尼对工作记忆的改善作用,为此药在我军的应用策略提供实验依据。方法:18名健康男性志愿者,在两次睡眠剥夺实验中交叉服用莫达非尼和安慰剂,睡眠剥夺时间从第一天的07:00到第3d的07:00,并于第二天的0:00、12:00和第三天的0:00分别服用莫达非尼100mg或安慰剂。采用随机双盲设计给药,并在第一天的07:00、第二天的02:00和14:00以及第三天的02:00和07:00安排工作记忆测验。结果:工作记忆测验中,两组的反应时和正确率均有统计学差异(P<0.01),莫达非尼组的反应时要快于安慰剂组,正确率也要高于安慰剂组。莫达非尼对工作记忆的改善效果随着睡眠剥夺时间的延长而更趋明显。结论:莫达非尼对睡眠剥夺条件下个体的工作记忆有改善作用,是较为理想的睡眠剥夺对抗药物。     

从睡眠剥夺树qu（TBC）尿液提取内源性“睡眠因子”的研究

本研究报道从睡眠剥夺（ＳＤ）４８－７２ｈ的灵长类原宗Ｔｕｐａｉａ ｂｅｌａｎｇｅｒｉ ｃｈｉｎｅｎ－ｓｉｓ（ＴＢＣ）提取内源性“睡眠因子”Ｓ２Ｃ和Ｓ４Ｂ。收集的尿液经超滤,清液冻干经Ｓｅｐｈａｄｅｘ Ｇ１５分离内源性“睡眠因子”Ｓ２Ｃ和Ｓ４Ｂ。收集的尿液经滤,清液冻干经ＳｅｐｈａｄｅｘＧ１５分离得到Ｆｒａｃｔｉｏｎ Ｉ－Ｖ。活性测定发现Ｆｒａｃｔｉｏｎ－Ⅲ（Ｓ２Ｃ）呈现显著δ－增强促眠效应。经Ｓｅ     

睡眠剥夺对大鼠咬肌超微结构的影响

目的:应用电镜观察睡眠剥夺对大鼠咬肌超微结构的影响.方法:35只Wistar大鼠,随机分为5组:睡眠剥夺1d组、5d组、9d组、正常对照组和大平台对照组.采用改良多平台睡眠剥夺法(modified multiple plat-form method,MMPM)建立大鼠SD模型,观察咬肌超微结构的变化.结果:睡眠剥夺5d组大鼠咬肌线粒体出现水肿,基质密度降低,线粒体嵴减少,肌纤维微血管内出现充血性改变;睡眠剥夺9d组大鼠咬肌线粒体出现严重空泡性变,肌纤维微血管出现更为严重的充血性改变.结论:睡眠剥夺可导致咬肌肌纤维微血管充血性改变和线粒体损伤,这种变化随时间的延长而加重.     

从睡眠剥夺树鼩（TBC）尿液提取内源性“睡眠因子”（sleep factor）的研究

本研究报道从睡眠剥夺（ＳＤ）４８—７２ｈ的灵长类原宗（ｐｒｉｍｉｔｉｖｅｓｔｏｃｋ）Ｔｕｐａｉａｂｅｌａｎｇｅｒｉｃｈｉｎｅｎｓｉｓ（ＴＢＣ）提取内源性“睡眠因子”（ｓｌｅｅｐｆａｃｔｏｒ）Ｓ２Ｃ和Ｓ４Ｂ。收集的尿液经超滤,清液冻干经ＳｅｐｈａｄｅｘＧ１５分离得到ＦｒａｃｔｉｏｎⅠ－Ⅴ。活性测定发现Ｆｒａｃｔｉｏｎ－Ⅲ（Ｓ２Ｃ）呈现显著δ－增强促眠效应。经ＳｅｐｈａｄｅｘＧ２５和ＳｅｐｈａｄｅｘＬＨ２０进一步净化的Ｓ４Ｂ也呈现显著δ－增强促眠效应。     

长期异相睡眠剥夺对大鼠能量代谢及血清甲状腺素水平的影响

目的：探讨长期异相睡眠剥夺对大鼠能量代谢及血清甲状腺素水平的影响。方法：采用小平台水环境法建立长期异相睡眠剥夺大鼠模型;检测其能量代谢变化;放射免疫法检测血清中甲状腺素水平。结果：睡眠剥夺后大鼠摄食量由（75.06±25.37）g/（d.kg）增加到（122.30±20.43）g/（d.kg）,体重由（360.89±43.01）g减轻到（295.97±37.95）g,体温由（37.62±1.12）℃先升高到（39.00±0.87）℃后又降低至（37.72±0.84）℃,基础代谢率由（1.69±0.36）mlO2/（g.h）增加到（2.40±0.09）mlO2/（g.h）与对照组相比差异显著（P〈0.05）;血清中游离三碘甲状腺原氨酸（FT3）水平由（3.38±0.88）pmol/L降低到（2.38±0.83）pmol/L,游离甲状腺素（FT4）由（14.62±3.62）pmol/L降低到（8.26±2.80）pmol/L与对照组相比差异显著（P〈0.05）。结论：长期异相睡眠剥夺可以显著影响大鼠的能量代谢和血清甲状腺素水平。     

快速眼动睡眠剥夺对大鼠恐惧消退再现的影响

目的：研究两种实验范式AAA和ABA（A、B表示不同场景）中快速眼动睡眠剥夺（RSD）对大鼠恐惧消退再现的影响。方法：1d大鼠适应环境;2d进行恐惧条件化;3d恐惧消退训练并进行RSD;4d进行恐惧消退再现检测。结果：AAA实验范式中,在恐惧消退再现检测阶段,0～6hRSD组大鼠的僵直水平显著高于对照组（P〈0．05）,其他阶段处理组与对照组大鼠的僵直水平都无显著性;ABA实验范式中,各阶段处理组与对照组大鼠的僵直水平都无显著性。结论：不同实验范式中RSD对恐惧消退影响不同,并且这种影响依赖于睡眠剥夺的时段。     

寒冷刺激对部分睡眠剥夺小鼠血细胞参数的影响

目的：探讨寒冷刺激,部分睡眠剥夺,以及部分睡眠剥夺的基础上再给予寒冷刺激等处理对小鼠血细胞参数的影响。方法：昆明小鼠24只,随机均分为4组（n=6）：对照组、寒冷组、不完全睡眠剥夺组和不完全睡眠剥夺加寒冷组。寒冷组每天给予（10±2）℃的低温处理4h,不完全睡眠剥夺组每天18：00至次日9：00剥夺睡眠,不完全睡眠剥夺加寒冷组在每天睡眠剥夺的基础上再给予4h寒冷刺激。连续处理4d后采血检测血常规和血沉率。结果：与对照组相比,寒冷刺激可使小鼠血液中淋巴细胞含量（P〈0．05）以及百分比（P〈0．01）显著增加;部分睡眠剥夺可使小鼠血液白细胞和淋巴细胞含量（P〈0．05）及百分比（P〈0．01）明显降低。不完全睡眠剥夺加寒冷刺激处理后与其它三组相比小鼠血液白细胞和淋巴细胞含量显著降低（P〈0．01）,而血沉率则显著升高（P〈0．01）。结论：部分睡眠剥夺会抑制机体免疫能力,在部分剥夺睡眠的基础上再给予寒冷刺激则将进一步抑制机体免疫能力并使血沉率加快,降低机体对外界环境变化的适应能力。     

36 h完全睡眠剥夺对客体工作记忆相关电位的影响

目的:采用事件相关电位(ERP)技术探讨36 h完全睡眠剥夺对客体工作记忆的影响。方法:本研究采用自身前后对照设计,16名睡眠质量良好的健康大学生(平均年龄为23岁,年龄范围21～28岁)分别在清醒状态下及36 h完全睡眠剥夺后接受2-back客体工作记忆任务,同时采集脑电数据。选用重复测量方差分析的方法比较睡眠剥夺前后与客体工作记忆有关的P2、N2、P3成分的波幅和潜伏期的差异。结果:在36 h完全睡眠剥夺后,与客体工作记忆加工相关的N2波的潜伏期显著延长(P<0.05),波幅减少但未见统计学差异(P>0.05); P2波潜伏期显著延长(P<0.05),波幅未见明显变化(P>0.05)。P3波波幅、潜伏期未见统计学差异(P>0.05)。结论:36h的完全睡眠剥夺影响了客体工作记忆相关电位,损害了个体的客体工作记忆加工能力。     

The effect of dopaminergic nigrostriatal system on sleep deprivation in rats

The analysis of the electrophysiological features of sleep-wakefulness cycle in Wistar rats for 9h after a 6h sleep deprivation was carried out. The delay of sleep rebound (since 2.5-3 h after deprivation) was found in the form of moderate increasing of slow-wave sleep and fast-wave sleep phases. According to these sleep-wakefulness cycle changes, a quantitative immunohistochemical study of tyrosine hydroxylase: a key enzyme of dopamine synthesis--and D1 and D2 receptors in nigro-striatal projections has been performed. After sleep, an elevation of D1 receptors immunoreactivity in caudate nucleus and reduction of tyrosine hydroxylase immunoreactivity in compact part of substancia nigra was found. After postdeprivation sleep, a decrease of D1 receptors immunoreactivity and increase of D2 receptors immunoreactivity in caudate nucleus together some increase of tyrosine hydroxilase immunoreactivity in substancia nigra compacta has been observed. These data can testify about active role of dopaminergic nigrostriatal system which provide at the same time with another neurotransmitters of the central nervous system the telencephalo-diencephalic interaction in sleep-wakefulness-sleep cycle.     

The ameliorative effect of fluoxetine on neuroinflammation induced by sleep deprivation

It is well known that sleep disorders are harmful to people's health and performance, and growing evidence suggests that sleep deprivation (SD ) can trigger neuroinflammation in the brain. The nucleotide‐binding domain and leucine‐rich repeat protein‐3 (NLRP 3) inflammasome is reported to be relevant to the neuroinflammation induced by SD , but the regulatory signaling that governs the NLRP 3 inflammasome in SD is still unknown. Meanwhile, whether the regulatory action of antidepressants in astrocytes could affect the neuroinflammation induced by SD also remains obscure. In this study, we were the first to discover that the antidepressant fluoxetine, a type of specific serotonin reuptake inhibitor widely used in clinical practice, could suppress the neuroinflammation and neuronal apoptosis induced by SD . The main findings from this study are as follows: (i) SD stimulated the expression of activated NLRP 3 inflammasomes and the maturation of IL ‐1β/18 via suppressing the phosphorylation of STAT 3 in astrocytes; (ii) SD decreased the activation of AKT and stimulated the phosphorylation of GSK ‐3β, which inhibited the phosphorylation of STAT 3; (iii) the NLRP 3 inflammasome expression stimulated by SD was partly mediated by the P2X7 receptor; (iv) an agonist of STAT 3 could significantly abolish the expression of NLRP 3 inflammasomes induced by an agonist of the P2X7 receptor in primary cultured astrocytes; (v) the administration of fluoxetine could reverse the stimulation of NLRP 3 inflammasome expression and function by SD through elevating the activation of STAT 3. In conclusion, our present research suggests the promising possibility that fluoxetine could ameliorate the neuronal impairment induced by SD .

     

Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression

The combination of total sleep deprivation (TSD) and light therapy (LT) in bipolar depression causes rapid antidepressant effects, and its mechanism of action has been hypothesized to involve the enhancement of all of the monoaminergic systems targeted by antidepressant drugs (serotonin, dopamine, norepinephrine). It is still unknown if the clinical effects are paralleled by changes in biological rhythms. In a before/after design of a study of biological correlates of response, 39 inpatients affected by Type I Bipolar Disorder whose current depressive episode was without psychotic features were treated for one week with repeated TSD combined with morning LT. Wrist actigraphy was recorded throughout the study. Two-thirds of the patients responded to treatment (50% reduction in Hamilton Depression score). Responders showed an increase in daytime activity, phase-advance of the activity-rest rhythm of 57 min compared to the pre-treatment baseline, and reduced nighttime sleep. Non-responders did not show significant changes in the parameters of their activity-rest rhythm. Phase advance of the activity-rest rhythm is an actimetric correlate of the antidepressant response to TSD and LT in bipolar depression. Results are consistent with the known effects of sleep-wake manipulations and neurotransmitter function on the suprachiasmatic nucleus.     

Sleep deprivation suppresses adult neurogenesis: Clues to the role of sleep in brain plasticity

Sleep and Biological Rhythms - Sleep is hypothesized to play a critical role in facilitating brain growth and plasticity. Neurogenesis in the adult hippocampus is a recently established model of...     

Effects of sleep deprivation on respiratory events during sleep in healthy infants

This study was designed to determine the effects of sleep deprivation on respiratory events during sleep in healthy infants. Ten unsedated full-term infants (1-6 mo) were monitored polygraphically during "afternoon naps" on a control day and on the day after sleep deprivation. Respiratory events, i.e., central apnea, obstructive apnea and hypopnea, and periodic breathing were tabulated. Results for respiratory events were expressed as 1) indexes of the total number of respiratory events and of specific respiratory events per hour of total sleep (TST), "quiet" sleep (QS) and "active" sleep (AS) times; 2) total duration of total and specific respiratory events, expressed as a percentage of TST, QS, and AS times. After sleep deprivation, significant increases were observed for 1) respiratory event (P less than 0.001), central apnea (P less than 0.05), and obstructive respiratory event (P less than 0.01) indexes; 2) respiratory event time as a percentage of TST (P less than 0.002) and as a percentage of AS time (P less than 0.001); 3) obstructive respiratory event time as a percentage of TST (P less than 0.01), QS (P less than 0.05), and AS times (P less than 0.002). The present study shows that short-term sleep deprivation in healthy infants increases the number and timing of respiratory events, especially obstructive events in AS.     

Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum

The metabotropic glutamate receptors 5 (mGlu5Rs) and the adenosine A2A receptors (A2ARs) have been reported to functionally interact in the striatum. The aim of the present work was to verify the hypothesis that the state of activation of A2A Rs could influence mGlu5R-mediated effects in the striatum. In electrophysiological experiments (extracellular recording in rat corticostriatal slices), the ability of the selective mGlu5R agonist CHPG to potentiate the reduction of the field potential amplitude induced by NMDA was prevented not only by the selective mGlu5R antagonist MPEP, but also by the selective A2AR antagonist ZM 241385. Analogously, the application of CHPG potentiated NMDA-induced toxicity (measured by LDH release) in cultured striatal neurons, an effect that was abolished by both MPEP and ZM 241385. Finally, the A2AR agonist CGS 21680 potentiated CHGP effects, an action that was reproduced and abolished, respectively, by forskolin (an activator of the cAMP/protein kinase A, PKA, pathway) and KT 5720 (a PKA inhibitor). The results indicate that A2ARs exert a permissive role on mGlu5R-induced effects in the striatum. Such an interaction may represent an additional target for the development of therapeutic strategies towards striatal disorders.